ADME 101™
FAQ: Using Plateable Hepatocytes in In Vitro Assays
- Test Systems & Methods
- December 13, 2022
- Halee McElhaney, Lucy Fahler
Plateable hepatocytes are often used for induction studies and to research metabolism, biochemistry, virology, host/pathogen interactions, and cell biology. Here,...
Ask Me Anything About In Vitro ADME, Drug-Drug Interaction Approaches and Strategies
- ADME 101™
- December 1, 2022
- Dr. Joanna Barbara
Last month, Dr. Joanna Barbara joined AAPS for an online Q&A in their ongoing “Ask the Experts” series. As regulatory...
Are in vitro drug metabolism and drug-drug interaction studies critical for an IND?
- ADME 101™
- November 1, 2022
- Dr. Andrew G. Taylor, Michael Millhollen, Isis Smith, Amara Millhollen
A Guide to What, Why & When to Conduct ADME Studies When drug developers are preparing their IND, drug metabolism...
4 Ways De-Risking Maximizes Compound Value
- ADME 101™
- August 31, 2022
- Michael Millhollen
Since most new drugs fail because of ADME/Tox, you can add considerable value to your compound by conducting early in...
Which Hepatocytes Should I Use for What Studies?
- Test Systems & Methods
- March 25, 2022
- Dr. Chris Bohl, Michael Millhollen, Isis Smith
Primary hepatocytes are considered the gold standard for ADME/DMPK studies because they are the most representative in vitro test system. However, not all hepatocyte formats…
What is DMPK and how does it fit into drug development?
- Drug Metabolism
- May 11, 2020
- Madison Esely-Kohlman
Drug metabolism and pharmacokinetics (DMPK) is a core discipline in drug development that considers the biotransformation of a drug compound...
ADME and Drug-Drug Interactions for the Toxicologist
- Drug Drug Interactions (DDI)
- April 28, 2020
- Madison Esely-Kohlman
Highlights from the recent webinar presented by our newest expert consultant, Dr. Pallavi Limaye In her recent webinar (now available for...
What is ADME and how does it fit into drug development?
- Drug Metabolism
- April 10, 2020
- Madison Esely-Kohlman, Dr. Brian Ogilvie
The main aim of drug development is to get a compound that has a therapeutic effect into the form of...
In Vitro Evaluation of Drug-Drug Interaction (DDI) Potential
- Enzyme Inhibition
- March 24, 2020
- Madison Esely-Kohlman, Zachary Mitts, Dr. Joanna Barbara
In its most recent in vitro drug interaction guidance update, the US Food and Drug Administration (FDA) emphasized harmony with the...
Four ways to optimize preclinical in vitro data to mitigate risk of late-stage clinical failure
- Consultancy
- March 9, 2020
- Madison Esely-Kohlman
1. Collect high-quality data to make informed, confident go/no go decisions for moving your drug candidate forward If you need...
Subscribe to our Newsletter
Stay up to date with our news, events and research
Do you have a question or a request for upcoming blog content?
We love to get your feedback